Schizophrenia: gender, family risk, and plasma homovanillic acid.
Plasma homovanillic acid concentration was assessed in 60 young schizophrenic patients, with and without first-degree relatives with schizophrenia, before treatment, and 3 days after starting haloperidol treatment. The baseline concentration of homovanillic acid in plasma was no different in the two groups before treatment; it was, however, significantly higher in the patients with relatives than in those without relatives diagnosed of schizophrenia after 3 days of haloperidol treatment.
D000293:Adolescent; D000328:Adult; D005190:Family; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006719:Homovanillic Acid / Q000097:blood*; D006801:Humans; D008297:Male; D012307:Risk Factors; D012559:Schizophrenia / Q000097:blood* / Q000188:drug therapy / Q000235:genetics*; D012727:Sex Characteristics
D006220:Haloperidol; D006719:Homovanillic Acid